Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
Provided By GlobeNewswire
Last update: Jun 10, 2025
NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will host a virtual key opinion leader (KOL) event on Monday, June 16, 2025 at 12:00 PM ET. To register, click here.
Read more at globenewswire.com3.29
+0.9 (+37.66%)
Find more stocks in the Stock Screener
GALT Latest News and Analysis
2 days ago - ChartmillThese stocks are moving in today's sessionKeep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
3 days ago - ChartmillWhich stocks are moving on Tuesday?Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
